Why the study?
It was unclear whether the magnitude or change in troponin concentration can differentiate causes of myocardial injury and infarction in practice.
Can the magnitude or change in high-sensitivity cardiac troponin concentration differentiate type 1 myocardial infarction from other causes of myocardial injury in patients with suspected acute coronary syndrome?
Can the magnitude or change in high-sensitivity cardiac troponin concentration differentiate type 1 myocardial infarction from other causes of myocardial injury in patients with suspected acute coronary syndrome?
High-sensitivity cardiac troponin concentrations at presentation are insufficient to distinguish type 1 myocardial infarction from other causes of myocardial injury and should not be used in isolation to guide management.
Answers are grounded in this paper and cite their sources.
Serial troponin change modestly improves type 1 MI discrimination; hypothesis-generating and should not yet change practice in suspected ACS.
BACKGROUND: Although the 99th percentile is the recommended diagnostic threshold for myocardial infarction, some guidelines also advocate the use of higher troponin thresholds to rule in myocardial infarction at presentation. It is unclear whether the magnitude or change in troponin concentration can differentiate causes of myocardial injury and infarction in practice. METHODS: In a secondary analysis of a multicenter randomized controlled trial, we identified 46 092 consecutive patients presenting with suspected acute coronary syndrome without ST-segment-elevation myocardial infarction. High-sensitivity cardiac troponin I concentrations at presentation and on serial testing were compared between patients with myocardial injury and infarction. The positive predictive value and specificity were determined at the sex-specific 99th percentile upper reference limit and rule-in thresholds of 64 ng/L and 5-fold of the upper reference limit for a diagnosis of type 1 myocardial infarction. Discrimination improved when troponin concentration and change in troponin were combined compared with troponin concentration at presentation alone (area under the curve, 0.661 [0.642-0.680] versus 0.613 [0.594-0.633]). CONCLUSIONS: Although we observed important differences in the kinetics, cardiac troponin concentrations at presentation are insufficient to distinguish type 1 myocardial infarction from other causes of myocardial injury or infarction in practice and should not guide management decisions in isolation. Registration: URL: https://www.clinicaltrials.gov; Unique identifier: NCT01852123.
No takes yet. Share an insight, caveat, or question.
Wereski et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: